Navigation Links
"Scientific Oktoberfest" Draws the Worldwide Leading Researchers in the Field of Chemical Biology to Munich
Date:9/9/2011

MUNICH, September 9, 2011 /PRNewswire/ --

The "Scientific Oktoberfest" will be this year's meeting point for some of the internationally most distinguished researchers in the field of Chemical Biology. The so-called "CIPSM Fest of Chemical Biology" will be held from the 15th to the 16th of September in the Department of Chemistry of the Ludwig-Maximilians-Universität (LMU) München.

At the two-day conference, 400 researchers from around the world will discuss state-of-the art research in various fields spanning from chemistry to biology and present their latest results in the fight against diseases like cancer or bacterial infections.

Speakers will be:

  • Shankar Balasubramanian
    Dept. of Chemistry, University of Cambridge UK
    "Sequencing Nucleic Acids: A Passage from Chemistry to Science and Medicine"
  • Thomas Carell
    CIPSM at the Dept. of Chemistry, Ludwig-Maximilians-Universität (LMU) München
    "The chemistry of genome development"
  • Chris Chang
    Dept. of Chemistry, UC Berkeley
    "Molecular imaging approaches to understanding metal and redox biology in the brain"
  • Jon Clardy
    Dept. of Chemistry & Chemical Biology, Harvard Med. School, Broad Inst., Harvard University
    "Bacterial Conversations"
  • Benjamin F. Cravatt III
    Dept. of Chemical Physiology, The Skaggs Institute, The Scripps Research Institute
    "Activity-based proteomics: applications for enzyme and inhibitor discovery"
  • François Diederich
    ETH Zürich, Lab. of Organic Chemistry
    "Molecular Recognition at Enzyme Active Sites"
  • Wilfred A. van der Donk
    Dept. of Chemistry, University of Illinois at Urba na-Champaign
    "Posttranslational modifications in natural product biosynthesis"
  • Michael Famulok
    Rheinische Friedrich-Wilhelms-Universität Bonn, Lab. of Chemical Biology
    "Insight into ErbB receptor signaling from a Chemical Biology perspective"
  • Itaru Hamachi
    Dept. of Synthetic Chemistry and Biological Chemistry, Kyoto University
    "Protein labeling and engineering in live cell systems"
  • Julius Rebek
    The Skaggs Institute for Chemical Biology, The Scripps La Jolla
    "Molecular Behavior in Small Spaces"
  • Peter G. Schultz
    The Scripps Research Institute, La Jolla
    "Synthesis at the Interface of Chemistry and Biology"
  • Mitsuhiko Shionoya
    Dept. of Chemistry, University of Tokyo
    "Bio-inspired Molecular Design of Supramolecular Architectures"
  • Hiroshi Sugiyama
    Dept. of Chemistry, Kyoto University
    "Chemical Biology that Controls DNA Structure and Function"
  • Christopher T. Walsh
    Harvard Medical School, Dept. of Chemistry & Chemical Biology, Harvard University
    "Thiazole Peptide Antibiotic Biosynthesis: A Cascade of Posttranslational Modifications"

For more information please visit http://www.cipsm.de/fest/

Contact:
Dr. Oliver Baron
Managing Director of the
Center For Integrated Protein Science Munich (CIPSM) at Ludwig-Maximilians-Universität (LMU) München
Department of Chemistry
81377 Munich
Germany
Tel: +49(0)89-2180-77880
E-mail: oliver.baron@cipsm.de 



'/>"/>
SOURCE Center For Integrated Protein Science Munich (CIPSM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
2. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
3. Cimzia Draws Even With Simponi at Six Months Post Launch According to Recent BioTrends Survey
4. China Medicine Corporation Voluntarily Withdraws Application for Nasdaq Listing
5. Centocor Ortho Biotech Products, L.P. Voluntarily Withdraws NDA for Trabectedin
6. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
7. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
8. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
9. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
10. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
11. BBK Worldwide Celebrates 25th Anniversary of Industry Leadership Through Innovation in Patient Enrollment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 8, 2016   GS1 US will hold ... them through GS1 Standards implementation to address the requirements ... Device Identification (UDI) rule. Scott Brown ... Gibson , senior director industry development, medical devices, GS1 ... GS1 US --> Scott Brown ...
(Date:2/8/2016)... Pa. , Feb. 8, 2016   ... November Research Group (NRG),s pharmacovigilance technology services ... system-related consulting services and an Oracle Argus Specialized ... services to Life Sciences companies. ... and expands HighPoint,s life sciences capabilities and provides ...
(Date:2/8/2016)... , Switzerland and PALO ALTO, Calif. ... in biological and chemical manufacturing, and Kodiak Sciences Inc., ... the treatment of retinal disease, announced today agreements for ... agreement, Lonza will manufacture material at multiple sites, including ... --> --> Retinal diseases, ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... Discover the Rocky Mountain ... 1,400 booths and 700 companies. Attendees also get to see the most incredible ... Garden & Home Show , at the Colorado Convention Center - 700 14th St. ...
(Date:2/8/2016)... ... February 08, 2016 , ... Joshua Rosenthal, PhD, Chief Scientific ... can use newly released government data on populations and physicians to better calculate ... capture the value they create to succeed in new economic models for value ...
(Date:2/7/2016)... Michigan (PRWEB) , ... February 07, 2016 , ... ... organ prolapse with the latest techniques and the most minimally invasive approaches. , ... organ prolapse, particularly after menopause. Other risk factors include surgery to the pelvic ...
(Date:2/6/2016)... ... February 06, 2016 , ... ... NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This ... an estimated 5000 perioperative nurses in attendance to study the latest evidence-based ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown that building ... the frequency and level of relapse. , At the 2016 iaedp ... will explore the critical tasks of the recovery phase and beyond including relapse ...
Breaking Medicine News(10 mins):